NJ A 4694
in committeeRequires prescription drug coverage for serious mental illness without prior authorization or utilization management, including step therapy.
New Jersey · 222 · lower
Quick answers
Did NJ A 4694 pass?
Not yet. NJ A 4694 is in committee as of 2026-03-16 and has not come to a final vote. Latest recorded action (2026-03-16): Introduced, Referred to Assembly Health Committee
What is NJ A 4694 about?
NJ A 4694 is a bill in the 222 titled “Requires prescription drug coverage for serious mental illness without prior authorization or utilization management, including step therapy.”.
Who sponsors NJ A 4694?
Pintor Marin, Eliana, Stanley, Sterley S., Speight, Shanique are the primary sponsors of NJ A 4694, joined by 8 cosponsors.
- Introduced
- 2026-03-16
- Latest action
- 2026-03-16 — Introduced, Referred to Assembly Health Committee
- Bill type
- bill
- Last updated
- —
Sponsors
- Pintor Marin, Elianaprimary
- Stanley, Sterley S.primary
- Speight, Shaniqueprimary
- Venezia, Michaelcosponsor
- Donlon, Margie, M.D.cosponsor
- Peterpaul, Luanne M., Esq.cosponsor
- Schnall, Alexandercosponsor
- Sampson, William B., IVcosponsor
- Haider, Shama A.cosponsor
- Dunn, Aura K.cosponsor
- Tully, Chriscosponsor
Committees
Not provided by source.
Action timeline
2026-03-16
Introduced, Referred to Assembly Health Committee
introduction,referral-committee
Versions
- IntroducedCompare
Documents
Votes
Not provided by source.
Related bills
- Companion bill: S 2918
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:27:43.923511Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NJ&identifier=A 4694. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.